BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 28659337)

  • 61. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
    Hernández L; Beà S; Bellosillo B; Pinyol M; Falini B; Carbone A; Ott G; Rosenwald A; Fernández A; Pulford K; Mason D; Morris SW; Santos E; Campo E
    Am J Pathol; 2002 Apr; 160(4):1487-94. PubMed ID: 11943732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
    Dejean E; Renalier MH; Foisseau M; Agirre X; Joseph N; de Paiva GR; Al Saati T; Soulier J; Desjobert C; Lamant L; Prósper F; Felsher DW; Cavaillé J; Prats H; Delsol G; Giuriato S; Meggetto F
    Leukemia; 2011 Dec; 25(12):1882-90. PubMed ID: 21778999
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Br J Haematol; 2015 Mar; 168(6):771-83. PubMed ID: 25559471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M; Cavalchire G
    Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
    Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
    Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
    Ahrendsen JT; Ta R; Li J; Weinberg OK; Ferry JA; Hasserjian RP; Meredith DM; Varma H; Sadigh S; Michaels PD
    Am J Clin Pathol; 2022 Aug; 158(2):300-310. PubMed ID: 35460414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.
    Giuriato S; Faumont N; Bousquet E; Foisseau M; Bibonne A; Moreau M; Al Saati T; Felsher DW; Delsol G; Meggetto F
    Cancer Biol Ther; 2007 Aug; 6(8):1318-23. PubMed ID: 17660712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ALK-positive anaplastic large cell lymphoma: an evolving story.
    Bonzheim I; Steinhilber J; Fend F; Lamant L; Quintanilla-Martinez L
    Front Biosci (Schol Ed); 2015 Jun; 7(2):248-59. PubMed ID: 25961700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
    Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
    Cha YJ; Kim HR; Shim HS
    J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
    Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.
    Amano Y; Ishikawa R; Sakatani T; Ichinose J; Sunohara M; Watanabe K; Kage H; Nakajima J; Nagase T; Ohishi N; Takai D
    Biochem Biophys Res Commun; 2015 Feb; 457(3):457-60. PubMed ID: 25596129
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
    Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
    Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma.
    Lyapichev KA; Tang G; Li S; You MJ; Cheng TJ; Miranda RN; Iyer S; Yin CC; Konoplev S; Bueso-Ramos C; Vega F; Medeiros LJ; Xu J
    Hum Pathol; 2021 Feb; 108():22-31. PubMed ID: 33221344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages.
    Mariño-Enríquez A; Dal Cin P
    Cancer Genet; 2013 Nov; 206(11):357-73. PubMed ID: 24091028
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Common ALK gene rearrangement in Asian CD30+ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue.
    Tai YC; Kim LH; Peh SC
    Pathology; 2003 Oct; 35(5):436-43. PubMed ID: 14555389
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
    Eyre TA; Khan D; Hall GW; Collins GP
    Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells.
    Armstrong F; Duplantier MM; Trempat P; Hieblot C; Lamant L; Espinos E; Racaud-Sultan C; Allouche M; Campo E; Delsol G; Touriol C
    Oncogene; 2004 Aug; 23(36):6071-82. PubMed ID: 15208656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background.
    Díaz de la Pinta FJ; Rodríguez Moreno M; Salgado RN; Carvajal García N; Santonja C; Pérez Buira S; Piris MA; Requena L; Manso R; Rodríguez-Pinilla SM
    Hum Pathol; 2023 Jul; 137():71-78. PubMed ID: 37127078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.